Form D · Venture Capital Fund

Westlake BioPartners Fund I, L.P.

Westlake Village, CA · CIK 0001749591

Offering snapshot reported Sep 4, 2018 · SEC filing

Reported sold
$320M
Offering amount: $320M
Investors reported
33
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 28, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 4, 2018Initial$320,000,000No comparison33SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-320610

Source: Form D, filed Sep 4, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

WESTLAKE BIOPARTNERS FUND I, L.P.

Investment adviser: WESTLAKE BIOPARTNERS, LLC

Gross asset value
$442M
Beneficial owners
35
ADV minimum commitment
$0

Reported in Form ADV on Mar 30, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator STANDISH MANAGEMENT, LLC SANTA MONICA, California, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor KPMG LLP SAN FRANCISCO, California, United States
Custodian GOLDMAN SACHS FUNDS GROUP CHICAGO, Illinois, United States Related to adviser: No
Custodian MERRILL LYNCH, PIERCE, FENNER & SMITH SAN FRANCISCO, California, United States Related to adviser: No
Custodian MORGAN STANLEY SMITH BARNEY BOSTON, Massachusetts, United States Related to adviser: No
Custodian SILICON VALLEY BANK, A DIVISION OF FIRST CITIZENS BANK SANTA CLARA, California, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

KPMG LLP
PCAOB 185

Filing source

Form ADV 2055857 · Mar 30, 2026 · Schedule D 7.B.(1), fund 805-2359059660

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Scott Ryles Executive
Beth Seidenberg Director
N/A Westlake Bio Partners Gp I, Llc Director

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
3075 Townsgate Road, Suite 140
Westlake Village, CA, 91361